Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer

Table 4 Spearman correlation analysis of clinical and biochemical variables with plasma levels of liver-type fatty acid-binding protein

Parameter	Breast cancer (n = 196)	p-value	Healthy controls (n = 57)	p-value
Age	0.320	< 0.0001	0.537	< 0.0001
Body mass index	0.353	< 0.0001	0.273	0.040
SBP	0.288	< 0.0001	0.268	0.044
DBP	0.158	0.027	0.281	0.034
Fasting glucose	0.282	0.018	0.448	0.001
Total cholesterol	− 0.176	0.095	0.091	0.500
Triglycerides (mg/dl)	0.180	0.094	0.278	0.036
HDL-C	− 0.168	0.122	− 0.089	0.513
LDL-C	− 0.183	0.088	0.059	0.673
AST	0.352	< 0.0001	0.526	< 0.0001
ALT	0.443	< 0.0001	0.515	< 0.0001
AST:ALT ratio	0.369	< 0.0001	0.297	0.025
APRI	0.191	0.012	0.380	0.004
Fibrosis-4 index	0.173	0.018	0.318	0.016
Creatinine	0.315	< 0.0001	0.342	0.009
Estimated GFR	− 0.386	< 0.0001	− 0.477	0.0002
Albumin	0.108	0.314	0.059	0.668
WBC count	0.126	0.079	− 0.002	0.988
Neutrophil count	0.122	0.119	− 0.069	0.612
Monocyte count	0.263	0.001	− 0.148	0.273
Lymphocyte count	0.161	0.038	0.121	0.371
Red blood cells	0.103	0.153	0.033	0.806
Hemoglobin	0.084	0.244	0.242	0.069
Hematocrit	0.019	0.794	0.185	0.169
Platelet count	0.020	0.785	0.016	0.905

SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AST aspartate transaminase, ALT alanine transaminase, APRI AST to platelet ratio index, GFR glomerular filtration rate, WBC white blood cell count

ISSN: 1477-7819